EMILY LUCENTE: Open Payments
NPI 1720536964 · LIHUE, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,355 in 55 payments from 9 companies in 2025. Trend: 2023 $1,120 · 2024 $1,115 · 2025 $1,355
Food & beverage: $1,290Education: $65
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 27 | $565 |
| AstraZeneca Pharmaceuticals LP | 20 | $562 |
| HARMONY BIOSCIENCES LLC | 2 | $85 |
| GENZYME CORPORATION | 1 | $32 |
| Insmed, Inc. | 1 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| Verona Pharma, Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $15 |
Products named: NUCALA, AIRSUPRA, TRELEGY ELLIPTA, TEZSPIRE, BREZTRI, FASENRA, DUPIXENT, Arikayce.
Industry payments across HI — which companies pay providers there.
